Michael Pennick

948 total citations
18 papers, 616 citations indexed

About

Michael Pennick is a scholar working on Psychiatry and Mental health, Nephrology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Pennick has authored 18 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Nephrology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Pennick's work include Attention Deficit Hyperactivity Disorder (8 papers), Parathyroid Disorders and Treatments (5 papers) and Magnesium in Health and Disease (5 papers). Michael Pennick is often cited by papers focused on Attention Deficit Hyperactivity Disorder (8 papers), Parathyroid Disorders and Treatments (5 papers) and Magnesium in Health and Disease (5 papers). Michael Pennick collaborates with scholars based in United States and United Kingdom. Michael Pennick's co-authors include Stephen J.P. Damment, Jeffrey G. Stark, Suma Krishnan, James Ermer, Amir Shojaei, Peter H. Hutson, Glen Frick, A. G. Lyne, Samuel W. Boellner and D. H. Staniforth and has published in prestigious journals such as Neuropharmacology, Clinical Pharmacokinetics and Drug Metabolism and Disposition.

In The Last Decade

Michael Pennick

18 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Pennick United States 14 222 158 123 107 72 18 616
M Nechifor Romania 11 81 0.4× 45 0.3× 52 0.4× 220 2.1× 17 0.2× 72 565
Tatsuya Hobara Japan 16 44 0.2× 29 0.2× 53 0.4× 82 0.8× 17 0.2× 76 873
S.C. Ho Hong Kong 16 70 0.3× 38 0.2× 26 0.2× 102 1.0× 18 0.3× 21 953
B Vengamma India 14 146 0.7× 22 0.1× 40 0.3× 63 0.6× 16 0.2× 66 634
Katie Budge United Kingdom 4 718 3.2× 39 0.2× 56 0.5× 21 0.2× 16 0.2× 8 1.1k
H Steinberg United States 11 124 0.6× 52 0.3× 83 0.7× 11 0.1× 19 0.3× 26 652
Susan Thys‐Jacobs United States 15 73 0.3× 148 0.9× 16 0.1× 81 0.8× 8 0.1× 21 1.2k
Paul Williams United States 15 167 0.8× 54 0.3× 21 0.2× 28 0.3× 6 0.1× 34 620
Shan Hai China 14 152 0.7× 15 0.1× 22 0.2× 71 0.7× 33 0.5× 27 1.0k
Nelly Jacob France 12 190 0.9× 15 0.1× 18 0.1× 31 0.3× 22 0.3× 28 878

Countries citing papers authored by Michael Pennick

Since Specialization
Citations

This map shows the geographic impact of Michael Pennick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pennick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pennick more than expected).

Fields of papers citing papers by Michael Pennick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Pennick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pennick. The network helps show where Michael Pennick may publish in the future.

Co-authorship network of co-authors of Michael Pennick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Pennick. A scholar is included among the top collaborators of Michael Pennick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Pennick. Michael Pennick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ermer, James, Michael Pennick, & Glen Frick. (2016). Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy. Clinical Drug Investigation. 36(5). 341–356. 49 indexed citations
2.
Hutson, Peter H., et al.. (2014). Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: A novel d-amphetamine pro-drug. Neuropharmacology. 87. 41–50. 56 indexed citations
3.
Häge, Alexander, Regina Dittmann, Michael Pennick, et al.. (2014). P.7.f.009 Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD. European Neuropsychopharmacology. 24. S733–S734. 1 indexed citations
4.
Pennick, Michael, et al.. (2014). Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells. Neuropsychiatric Disease and Treatment. 10. 2275–2275. 20 indexed citations
5.
6.
Pennick, Michael, et al.. (2012). Lanthanum Carbonate Reduces Urine Phosphorus Excretion: Evidence of High-Capacity Phosphate Binding. Renal Failure. 34(3). 263–270. 12 indexed citations
7.
Bronner, Félix, Boris M. Slepchenko, Michael Pennick, & Stephen J.P. Damment. (2008). A Model of the Kinetics of Lanthanum in Human??Bone, Using Data Collected during the Clinical Development of the Phosphate Binder Lanthanum Carbonate. Clinical Pharmacokinetics. 47(8). 543–552. 22 indexed citations
8.
Krishnan, Suma, Michael Pennick, & Jeffrey G. Stark. (2008). Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate. Clinical Drug Investigation. 28(12). 745–755. 65 indexed citations
9.
Damment, Stephen J.P. & Michael Pennick. (2008). Clinical Pharmacokinetics of the Phosphate Binder Lanthanum Carbonate. Clinical Pharmacokinetics. 47(9). 553–563. 75 indexed citations
10.
11.
Damment, Stephen J.P. & Michael Pennick. (2007). Systemic lanthanum is excreted in the bile of rats. Toxicology Letters. 171(1-2). 69–77. 44 indexed citations
12.
Boellner, Samuel W., et al.. (2007). Pharmacokinetics of a Guanfacine Extended‐Release Formulation in Children and Adolescents with Attention‐Deficit–Hyperactivity Disorder. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(9). 1253–1262. 48 indexed citations
13.
14.
Pennick, Michael, et al.. (2006). Absolute Bioavailability and Disposition of Lanthanum in Healthy Human Subjects Administered Lanthanum Carbonate. The Journal of Clinical Pharmacology. 46(7). 738–746. 98 indexed citations
15.
Toppmeyer, Deborah, Murugesan Gounder, Viral Vyas, et al.. (2003). A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy.. PubMed. 9(8). PI99–104. 8 indexed citations
16.
Bier, Melinda C., et al.. (1997). Personal Empowerment in the Study of Home Internet Use by Low-Income Families. Journal of Research on Computing in Education. 30(2). 107–121. 21 indexed citations
17.
Harrell, Andrew W., et al.. (1993). Evidence that famciclovir (BRL 42810) and its associated metabolites do not inhibit the 6 beta-hydroxylation of testosterone in human liver microsomes.. Drug Metabolism and Disposition. 21(1). 18–23. 16 indexed citations
18.
Staniforth, D. H. & Michael Pennick. (1990). Human pharmacology of renzapride: a new gastrokinetic benzamide without dopamine antagonist properties. European Journal of Clinical Pharmacology. 38(2). 161–4. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Nechifor Breakdown of academic impact, for papers by Tatsuya Hobara Breakdown of academic impact, for papers by S.C. Ho Breakdown of academic impact, for papers by B Vengamma Breakdown of academic impact, for papers by Katie Budge Breakdown of academic impact, for papers by H Steinberg Breakdown of academic impact, for papers by Susan Thys‐Jacobs Breakdown of academic impact, for papers by Paul Williams Breakdown of academic impact, for papers by Shan Hai Breakdown of academic impact, for papers by Nelly Jacob
Rankless by CCL
2026